Home Cart 0 Sign in  
X

[ CAS No. 92136-39-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 92136-39-5
Chemical Structure| 92136-39-5
Chemical Structure| 92136-39-5
Structure of 92136-39-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 92136-39-5 ]

Related Doc. of [ 92136-39-5 ]

Alternatived Products of [ 92136-39-5 ]

Product Details of [ 92136-39-5 ]

CAS No. :92136-39-5 MDL No. :MFCD07367245
Formula : C8H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :DSPYCWLYGXGJNJ-UHFFFAOYSA-N
M.W : 155.19 Pubchem ID :11073648
Synonyms :
N-Boc-Propargylamine
Chemical Name :N-Boc-Propargylamine

Calculated chemistry of [ 92136-39-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.62
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.25
TPSA : 38.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.51 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.35
Log Po/w (XLOGP3) : 1.04
Log Po/w (WLOGP) : 1.22
Log Po/w (MLOGP) : 1.38
Log Po/w (SILICOS-IT) : 0.73
Consensus Log Po/w : 1.34

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.19
Solubility : 9.94 mg/ml ; 0.0641 mol/l
Class : Very soluble
Log S (Ali) : -1.44
Solubility : 5.7 mg/ml ; 0.0367 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.3
Solubility : 7.71 mg/ml ; 0.0497 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.36

Safety of [ 92136-39-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P273-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335-H412 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 92136-39-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 92136-39-5 ]
  • Downstream synthetic route of [ 92136-39-5 ]

[ 92136-39-5 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 92136-39-5 ]
  • [ 2450-71-7 ]
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 3, p. 1254 - 1264
  • 2
  • [ 92136-39-5 ]
  • [ 78888-18-3 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With n-butyllithium; copper(l) cyanide In tetrahydrofuran at -78℃; for 0.25 h;
Stage #2: With tri-n-butyl-tin hydride In tetrahydrofuran at -78℃; for 0.333333 h;
Stage #3: at -78℃; for 1 h;
A solution of copper cyanide (1.1Sg, 12.9 mmol) in THF (30 mL) at ?78 C. was treated slowly with n-butyllithium (16.9 mL, 27.1 mmol), stirred for 15 minutes at ?78 C., treated with tributyltin hydride (7.88 g, 7.30 mL, 27.1 mmol) over a period of 5 minutes, stirred for 15 minutes, treated with tert-butyl 2-propynylcarbamate (2.00 g, 12.9 mmol) in tetrahydrofuran (7 mL), stirred at ?780C for 1 hour, and treated with a 9:1 aqueous solution of ammonium chloride:ammonium hydroxide (250 mL) and dichloromethane (200 mL). The suspension was filtered through a short pad of diatomaceous earth (Celite). The organic phase of the filtrate was washed with brine and concentrated. The residue was purified on silica gel using 1-2percent ethyl acetate/heptane to provide the desired product (3.66 g, 63percent). 1H NMR (400 MHz, CDCl3) ? 6.08 (dt, B part of an AB system, J=19.3 Hz, 1.3 Hz, 1H); 5.93 (dt, A part of an AB system, J=19.3 Hz, 4.8 Hz, 1H), 4.59 (br s, 1H), 3.78 (br s, 2H), 1.45 (s, 9H), 1.32-1.26, (m, 12H), 0.90-0.85 (m, 15H).
63% With ammonium hydroxide; n-butyllithium; ammonium chloride; tri-n-butyl-tin hydride In tetrahydrofuran; n-heptane; dichloromethane; ethyl acetate EXAMPLE 314A
tert-butyl allylcarbamate
A solution of copper cyanide (1.15 g, 12.9 mmol) in THF (30 mL) at -78° C. was treated slowly with n-butyllithium (16.9 mL, 27.1 mmol), stirred for 15 minutes at -78° C., treated with tributyltin hydride (7.88 g, 7.30 mL, 27.1 mmol) over a period of 5 minutes, stirred for 15 minutes, treated with tert-butyl 2-propynylcarbamate (2.00 g, 12.9 mmol) in tetrahydrofuran (7 mL), stirred at -78° C. for 1 hour, and treated with a 9:1 aqueous solution of ammonium chloride:ammonium hydroxide (250 mL) and dichloromethane (200 mL).
The suspension was filtered through a short pad of diatomaceous earth (Celite.(R).).
The organic phase of the filtrate was washed with brine and concentrated.
The residue was purified on silica gel using 1-2percent ethyl acetate/heptane to provide the desired product (3.66 g, 63percent).
1H NMR (400 MHz, CDCl3) δ 6.08 (dt, B part of an AB system, J=19.3 Hz, 1.3 Hz, 1H); 5.93 (dt, A part of an AB system, J=19.3 Hz, 4.8 Hz, 1H), 4.59 (br s, 1H), 3.78 (br s, 2H), 1.45 (s, 9H), 1.32-1.26, (m, 12H), 0.90-0.85 (m, 15H).
63%
Stage #1: With n-butyllithium; copper(I) cyanide In tetrahydrofuran at -78℃; for 0.25 h;
Stage #2: With tri-n-butyl-tin hydride In tetrahydrofuran for 0.333333 h;
tert-butyl allylcarbamate
A solution of copper cyanide (1.15 g, 12.9 mmol) in THF (30 mL) at -78° C. was treated slowly with n-butyllithium (16.9 mL, 27.1 mmol), stirred for 15 minutes at -78° C., treated with tributyltin hydride (7.88 g, 7.30 mL, 27.1 mmol) over a period of 5 minutes, stirred for 15 minutes, treated with tert-butyl 2-propynylcarbamate (2.00 g, 12.9 mmol) in tetrahydrofuran (7 mL), stirred at -78° C. for 1 hour, and treated with a 9:1 aqueous solution of ammonium chloride:ammonium hydroxide (250 mL) and dichloromethane (200 mL).
The suspension was filtered through a short pad of diatomaceous earth (Celite.(R).).
The organic phase of the filtrate was washed with brine and concentrated.
The residue was purified on silica gel using 1-2percent ethyl acetate/heptane to provide the desired product (3.66 g, 63percent).
1H NMR (400 MHz, CDCl3) δ 6.08 (dt, B part of an AB system, J=19.3 Hz, 1.3 Hz, 1H); 5.93 (dt, A part of an AB system, J=19.3 Hz, 4.8 Hz, 1H), 4.59 (br s, 1H), 3.78 (br s, 2H), 1.45 (s, 9H), 1.32-1.26, (m, 12H), 0.90-0.85 (m, 15H).
Reference: [1] Chemical Communications, 2015, vol. 51, # 12, p. 2384 - 2387
[2] Patent: US2005/20619, 2005, A1, . Location in patent: Page 58-59
[3] Patent: US2005/26944, 2005, A1,
[4] Patent: US2005/43347, 2005, A1, . Location in patent: Page/Page column 67-68
  • 3
  • [ 24424-99-5 ]
  • [ 2450-71-7 ]
  • [ 92136-39-5 ]
YieldReaction ConditionsOperation in experiment
100% at 0℃; Di-tert-butyl dicarbonate (17.5 g, 80.0 mmol, 1.0 equiv) was added dropwise at 0 °C to a soln of prop-2-yn-1-amine (5.49 mL, 80.0 mmol, 1.0 equiv) in CH2Cl2 (160 mL). After 1 h of stirring, the solvent was removed in vacuo and the resulting colorless oil was dried under high vacuum overnight to yield a white solid (12.4 g, quantitative yield), which was used as such without further purification. The spectral data corresponds to that reported in the literature.1Rf = 0.38 (Hexanes/AcOEt 9:1). mp = 41-42 °C (lit.:[1] 40-44 °C). 1H NMR (500 MHz, CDCl3): d (ppm) 4.94 (br s, 1H), 3.91 (br d, J = 2.5 Hz, 2H), 2.23 (t, J = 2.5 Hz, 1H), 1.45 (s, 9H). 13C NMR (126 MHz, CDCl3): d (ppm) 155.2, 80.1, 79.9, 71.1, 28.2.
99.4% With triethylamine In dichloromethane (7a):
To a solution of prop-2-ynylamine (5.50 g, 0.10 mmol), Et3N (14 ml, 1.5 eq) in CH2Cl2 (200 mL) was added (Boc)2O (21.8 g, 1.0 eq).
The reaction mixture was stirred at rt for 2.5 h, then concentrated, the residue was passed through a silica gel pad, eluted with 20percent ethyl acetate-hexanes (500 mL), the eluant was concentrated to give prop-2-ynyl-carbamic acid tert-butyl ester (15.40 g, 99.4percent) as a crystalline solid.
99% at 20℃; Cooling with ice 5.5 g of propargylamine (100 mmol) was dissolved in 50 mL of ethyl acetate,Boc anhydride (32 g, 147 mmol) was added under ice-water bath,The reaction was allowed to warm to room temperature overnight,The organic phase was washed with 1percent hydrochloric acid solution,Saturated sodium bicarbonate solution and saturated brine, dried over anhydrous sodium sulfate and spun dry to give product 13 as a yellow solid (15.3 g, 99 mmol, 1 99percent).
98% at 0℃; for 0.416667 h; test-Butyl prop-2-ynylcarbamate (46). To a solution of propargylamine (803 mg, 14.6 mmol) in CH2C12 (15 mL) at 0 °C was added a solution of di-tert-butyl dicarbonate (2.67 g, 15.3 mmol) in CH2C12 (20 mL) via dropping funnel over 25 min, the ice bath was removed and the resultant solution was stirred at ambient temperature for 30 min. The solvent was removed in vacuo and the crude material was chromatographed on silica gel (EtOAc/Hex, 10/90, Rf= 0.28) to afford the title compound 46 (2.23 g, 98percent yield) as a white solid: mp = 39-40 °C ; 1H NMR (CDC13) 8 4.79 (s, 1H), 3.90 (br s, 2H), 2.20 (m, 1H), 1.43 (s, 9H); LRMS (ESI) m/z calcd for CsHl3NNa02 [M + Na] + 178, found 178.
90% for 12 h; Step A: tert-Butyl prop-2-ynylcarbamate: A solution of propargylamine (5.00 gs 90.8 mmol) and BoC2O (18.8 g, 86.2 mmol) in DCM (200 mL) was stirred for 12 hours. The mixture was washed with dilute aqueous HCl, and the organic layer was dried (Na2SOa), filtered, and concentrated in vacuo. The resulting oil crystallized upon standing to give 12.0 g (90percent) of the title compound. 1H NMR (400 MHz, CDCl3) δ 4.78 (br s, IH), 3.92 (s, 2H), 2.22 (s, IH), 1.46 (s. 9H).
90% With triethylamine In dichloromethane at 20℃; Prop-2-ynyl-carbamic acid tert-butyl ester 2:BocHNDi-tert-butyl dicarbonate (9.0g, 40.0mmol) was added to a solution ofpropargylamine (2.0g, 36.0mmol) and triethylamine (7.6ml_, 54.5mmol) in dichloromethane (20ml_) at rt. After overnight stirring, the reaction was washed with saturated solution of NH4CI and brine. The organic layer was dried over Na2S04, filtered and evaporated to provide Boc-propargylamine 2 as a brown viscous oil (5.1 g, 36.0mmol, 90percent yield).
90% at 20℃; for 4 h; Inert atmosphere To a stirred solution of propargyl amine (2.0 g, 36.3 mmol) in THF (30 mL) was added di-tert-butyl dicarbonate (8.78 g, 40.2 mmol, 1.1 equiv) at rt. The solution was stirred at the same temperature for 4h, and then concentrated in vacuo. The resulting residue was dissolved in EtOAc (100 mL), washed with water (3×20 mL) and brine (20 mL) and then dried over anhydrous Na2SO4. After removal of the solvent in vacuo, N-Boc-propargylamine (5.11 g, 32.9 mmol, 90percent) was obtained as a yellow solid, which was pure enough and used in the subsequent reaction without further purification. mp 38-39 °C (Lit.13 41-42 °C). 1H NMR (500 MHz, CDCl3) δ 4.81 (brs, 1H), 3.89 (s, 2H), 2.19 (t, J = 2.5 Hz, 1H), 1.42 (s, 9H); 13C NMR (125 MHz, CDCl3, ppm): δ 155.92, 80.76, 71.86, 30.99, 28.97, 28.04.
90%
Stage #1: With triethylamine In dichloromethane at 20℃; for 0.25 h;
Preparation of Compound 29
A solution of amine 28 (10.0 g, 0.181 mmol) in CH2Cl2 (100 mL) was charged with triethylamine (24.0 g, 0.237 mmol) at room temperature, and the reaction mixture was stirred at room temperature for 15 min. (Boc)2O (43.5 g, 0.199 mmol) was added dropwise to the stirring solution. The reaction mixture was partitioned between CH2Cl2 (100 mL) and water (100 mL). The aqueous layer was separated and extracted with CH2Cl2 (100 mL). The combined organic extracts were washed with brine, dried over Na2SO4, and concentrated to afford compound 29 (25.0 g, 90percent) as a brown solid. 1H NMR (400 MHz, CDCl3): δ 4.82-4.72 (br s, 1H), 3.92-3.91 (m, 2H), 2.21 (t, J=2.4 Hz, 1H), 1.67 (s, 1H), 1.45 (s, 9H).
90% for 12 h; Step B: Preparation of tert-butyl prop-2-ynylcarbamate: A solution of propargylamine (5.00 g, 90.8 mmol) and BoC2O (18.8 g, 86.2 mmol) in DCM (200 mL) was stirred for 12 hours. The mixture was washed with dilute aqueous HCl, and the organic layer <n="20"/>was dried (Na2SO4), filtered, and concentrated in vacuo. The resulting oil crystallized upon standing to give 12.0 g (90percent) of the title compound. 1H NMR (400 MHz, CDCl3) δ 4.78 (br s, IH), 3.92 (s, 2H), 2.22 (s, IH)5 1.46 (s, 9H).
90% for 12 h; Step B: Preparation of tert-butyl prop-2-ynylcarbamate: A solution of propargylamine (5.00 g, 90.8 mmol) and BoC2O (18.8 g, 86.2 mmol) in DCM (200 mL) was stirred for 12 hours. The mixture was washed with dilute aqueous HCl, and the organic layer was dried (Na2SO4), filtered, and concentrated in vacuo. The resulting oil crystallized upon standing to give 12.0 g (90percent) of the title compound. 1H NMR (400 MHz5 CDCl3) δ 4.78 (br s, IH), 3.92 (s, 2H), 2.22 (s, IH)5 1.46 (s, 9H).
86% With triethylamine In dichloromethane at 0 - 20℃; for 3.5 h; To a solution of compound 154 (500 mg, 9.00 mmol) in CH2Cl2 (50 mL) was added TEA (1.63 mL, 11.7 mmol) and Boc2O (2.16 g, 9.90 mmol) at 0° C. The reaction mixture was continued to be stirred at 0° C. for 0.5 h, allowed to be warmed to room temperature and stirred for 3 h. Then the mixture was partitioned between CH2Cl2 (50 mL) and water (50 mL). The aqueous layer was separated and extracted with CH2Cl2 (2×50 mL). The combined organic extracts were washed with brine, dried over Na2SO4, concentrated, the residue was purified by column chromatography (silica gel, 2:3 hexanes/EtOAc) to afford desired compound 155 (1.20 g, 86percent) as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 4.70 (br s, 1H), 3.91 (dd, J=5.3, 2.2 Hz, 2H), 2.21 (t, J=2.7 Hz, 1H), 1.45 (s, 9H).
82% at 0 - 20℃; for 2.5 h; Di-tert-butyl-dicarbonate (10 g, 47 mmol, 1 equiv.) was dissolved in CH2Cl2 (0.2 M) and cooledd own to 0 C. 3-Amino-1-propyne (2.6 g, 47 mmol, 1 equiv.) was added at 0 C over a period of 30 min. Then, the mixture was allowed to warm to room temperature and stirred for 2 hours. When the reaction was completed by TLC, the solvent was evaporated and n-Pentane was added. The solution was left on standing in the refrigerator for 12 h. The precipitate was collected by filtration to afford 6 g of the N-Boc-propargylamine (82percent) as a white solid.
80% for 2 h; Inert atmosphere To a stirred solution of propargylamine (0.83 mL, 12.9mmol, 1 eq.) in dry DCM (13 mL) under nitrogen, was added dropwise a solution of di-tert-butyldicarbonate (2.81 g, 12.9 mmol, 1 eq.) in dry DCM (7 mL) and the reaction was stirred for 2 h.The organic layer was washed with an aqueous solution of HCl (1 N), then with a saturatedaqueous solution of NaHCO3. The aqueous layer was extracted with DCM, then the combinedorganic layers were dried over MgSO4, filtered and concentrated under vacuum. The cruderesidue was purified by flash column chromatography on silica gel (cyclohexane/EtOAc: 80/20)to afford tert-butyl prop-2-yn-1-ylcarbamate (1.6 g 10.4 mmol, 80percent) as a white solid. Thiscompound has been previously reported.S1
79% at 0 - 20℃; for 1 h; A solution of 1.28 ml (6.00 mmol, 1.1 eq.) of Boc2O in 15 ml of dry CH2Cl2 was addeddropwise to a solution of 0.348 ml (5.45 mmol, 1.0 eq.) of propargyl amine in 15 ml of dryCH2Cl2 at 0°C. The reaction mixture was stirred at r.t. for 1 h. After TLC showed completeconsumption of starting material, solvent was removed under reduced pressure. The crudeproduct was purified by flash column chromatography (cHex/EtOAc 20:1 – 10:1). Theproduct was obtained as an off-white solid (yield: 0.667 g, 4.303 mmol, 79 percent).
75% at 0 - 20℃; for 1.5 h; Di-tert-butyl-dicarbonate (21.8 mg, 100.0 mmol) was dissolved in THF (25 mL) and the solution cooled to 0° C. and treated dropwise with a solution of propargylamine (Aldrich, 5.0 g, 90.0 mmol) keeping the temperature below 15° C. The mixture was stirred at rt for 1.5 h then concentrated under vacuum. The residue was dissolved in hexanes and filtered through a column of silica gel using 0-100percent CH2Cl2/hexanes to elute the product. The eluent containing the product was concentrated in vacuo to give a colorless oil which was dissolved in hexanes (150 mL) and cooled to 0° C. to give white crystals. The crystals were collected by filtration and dried under vacuum to give the title compound (10.5 g, 75percent). 1H NMR (CDCl3) δ 4.75 (s, 1H), 3.95 (s, 2H), 2.25-2.24 (m, 1H), 1.48 (s, 9H).
74% at 23 - 28℃; for 2 h; tert -butyl prop-2-yn-l-ylcarbamate (7) [0153] Into a reactor was added propagylamine (10.0kg, 182mol) and MTBE (154L). A B0C2O solution was prepared by dissolving B0C2O (41.3kg, 190 mol) in MTBE (61L) and transferred over a minimum of 60min to the propargyamine solution while maintaining a temperature between 23 and 28 °C. The reaction mixture was stirred for at least lh until >98.0percent conversion was obtained by GC analysis. A solution of sodium bisulfate (5.6kg of NaHSC>4 n 44L water) was added over a minimum of 15min while maintaining the temperature between 20 and 25 °C and stirred for 20min. The phases were separated and washed as before with a solution of sodium bisulfate (5.6kg of NaHSC>4 m 44L water). The resulting organic phase was washed with a sodium bicarbonate solution (4.0kg in 44L water) and water (2 x 47L). The organic phase was concentrated using a maximum jacket temperature of 40 °C until 62kg remained in the reactor. Heptane (186L) is added over a minimum of 20min while maintaining the temperature between 35 and 40 °C. The mixture was concentrated using a maximum jacket temperature of 40 °C until 70kg remained in the reactor. The mixture was cooled to 0 to 5 °C over a minimum of 3h and stirred for lh at 0 to 5 °C. The mixture was filtered and washed with heptane at 0 to 5 °C (2 x 15L). The wet cake was dried under vacuum at 25 to 30 °C to provide 20.9kg (74percent yield) of 7. 3/4 NMR (300 MHz, CDCLj δ 4.70 (s, 1H), 3.92 (d, J= Hz, 2H), 2.22 (m, 1H), 1.45 (s, 9H); Elemental Anal. Calcd. for C8H13N02: C, 61.91; H, 8.44; N, 9.03; 0, 20.62. Found: C, 61.99; H, 8.36; N, 9.11; 0, 20.54.
72% With triethylamine In dichloromethane at 20℃; for 3 h; To a solution of 2-PROPYN-1-AMINE (2 g, 36.4 mmol, 1 equiv) in CH2CI2 (20 mi) were added NEt3 (5.3 MI, 38.18 MMOL, 1.05 equiv) and bis (1, 1-dimethylethyl) dicarbonate (8.32 g, 38.18 mmol, 1.05 equiv). The resulting mixture was stirred at room temperature for 3 h then poured in a 2N aqueous HCI solution. The two layers were separated and the organic phase was washed with a saturated aqueous NAHC03 solution then dried over MGS04 and concentrated in VACUO TO give 1, 1-dimethylethyl 2-propyn-1-ylcarbamate (D317) (4.05 g, 72percent) as a colourless crystal.
72% With triethylamine In dichloromethane at 20℃; for 3 h; To a solution OF 2-PROPYN-1-AMINE (2 g, 36.36 mmol, 1 equiv) in CH2CI2 (20 ML) at room temperature were added NEt3 (5.3 ml, 38.18 mmol, 1.05 equiv) and bis (1,1- dimethylethyl) dicarbonate (8.32 g, 38.18 mmol, 1.05 equiv) and the resulting mixture was stirred at room temperature for 3 h then washed with a 2N aqueous HCI solution and a saturated NAHC03 aqueous solution, dried over MGS04 and concentrated in vacuo to give 1, 1-DIMETHYLETHYL 2-PROPYN-1-YLCARBAMATE (D38) (4.05 g, 72percent) as colourless needles which were used in the next step without further purification.
71% With triethylamine In dichloromethane at 20℃; for 16 h; Cooling with ice (0049) To a solution of prop-2-yn-1-amine (5.0 g, 90.9 mmol) and Et3N (18.4 g, 181.8 mmol) in DCM (100 mL) was added (Boc)2O (23.8 g, 109.1 mmol) dropwise while cooling the reaction mixture with an ice bath. The resulting mixture was removed from the ice bath once the addition was completed, and was then stirred at room temperature for 16 h. When the reaction was complete, the mixture was diluted with DCM (200 mL), washed with brine (100 mL_3), and the organic layer was then dried over Na2SO4 and then concentrated in vacuo. The residue was purified by column chromatography on silica gel (PE:EtOAc=100:1÷10:1) to give 1672-1 (10 g, 71percent) as a colorless oil. MS 178.3 [M+23]+, 100.3 [M_56]+.
67% With sodium hydrogencarbonate In tetrahydrofuran; water EXAMPLE 516A
tert-butyl prop-2-ynylcarbamate
A solution of propargyl amine (2.32 g, 42.1 mmol) in THF (75 mL) and water (200 mL) was treated with a saturated sodium bicarbonate solution (5 mL), followed by the dropwise addition of a solution of di-tert-butyl-dicarbonate (9.19 g, 42.1 mmol) in THF (20 mL).
The solution was stirred overnight at room temperature, concentrated in vacuo to remove THF, extracted with ethyl acetate.
The combined organics were washed with brine, dried (MgSO4) and concentrated to provide 4.37 g (67percent yield) of the desired product. 1H NMR (300 MHz, CHLOROFORM-D) δ ppm 1.46 (s, 9H), 2.22 (t, J=2.54 Hz, 1H), 3.92 (dd, J=5.26, 2.20 Hz, 2H), 4.68 (s, 1H).
67.6% With triethylamine In dichloromethane at 20℃; for 2.5 h; Propargyl amine (25.18 g, 0.448 mol), triethylamine (55.52 g, 0.549 mol) and dichloromethane 400 ml were added to a four-necked flask, and while cooling the reaction solution in a water bath (20 ° C.) Di-tert-butyl carbonate (118.15 g, 0.541 mol) was added dropwise over 30 minutes. After completion of the dropwise addition, after stirring for 2 hours, 300 ml of saturated brine and 200 ml of dichloromethane were added to the reaction solution and extracted. The obtained organic layer was dried with magnesium sulfate. After removing the desiccant, the solvent of the obtained solution was distilled off to obtain a pale yellow oil. Purification by recrystallization (hexane) gave N-Boc-propargylamine as a white solid (yield: 47.01 g, yield: 67.6percent).
65% With sodium hydrogencarbonate In water Propargylamine (5.50 g, 0.1 mol) and di-tert-butyl dicarbonate (4.36 g, 2 eq.) were suspended together in 100 mL of a 10percent aqueous solution of NaHCO3. Reaction mixture was stirred overnight and extracted by EtOAc (3x20 mL). The organic phases were combined together, washed with citric acid 10percent aq., dried over MgSO4, filtered and evaporated, providing compound 18d as white solid (10.1 g, 65percent yield). 1H N MR (CDCI3) δ 4.72 (bs, 1 H), 3.91 (d, J= 3.0 Hz1 2H), 2.22 (t, J= 2.9 Hz, 1 H), 1.51 (s, 9H).
17% at 0 - 20℃; for 3.25 h; 14C. Prop-2-ynyl-carbamic acid tert-butyl ester; Di-fert-butyl dicarbonate (19.8g, 90.8 mmol) was dissolved in anhydrous dichloromethane (36 ml) and then added dropwise over 15 minutes to a solution of prop-2-ynylamine (6.22 ml, 90.8 mmol) in anhydrous dichloromethane (36 ml) at 0 0C. The resulting solution was stirred at room temperature for 3 hours. The solvent was removed under reduced pressure to leave a liquid that crystallized on standing. The solid was triturated with petroleum ether, filtered then dried to yield the title compounds as a yellow crystalline solid (2.45g, 17percent yield). 1H NMR (CDCl3) δ , 1.47 (9H, s), 2.23 (IH, t), 3.94 (2H, br s).
4.1 g at 20℃; for 1 h; To a solution of prop-2-yn-1-amine (245, 2.1 g, 38.2 mmol) in THF (30 mL) was added(Boc)20 (15 g, 68.8 mmol ). After stirring at room temperature for 1 h, the reaction mixturewas concentrated in vacuo to afford the residue, which was purified by column chromatography with a gradient elution of hexane (100percent) to hexane (80percent) and EtOAc (20percent) to provide tertbutyl prop-2-yn-1-ylcarbamate (246, 4.1 g, 26.4 mmol); ‘H NMR (300 MHz, CDC13): ö 4.70 (s, 1H), 3.85 (d, J= 3.0 Hz, 2H), 2.15 (t, J 2.7 Hz, 1H), 1.38 (s, 9H).

Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 17, p. 2199 - 2202
[2] Organic Letters, 2014, vol. 16, # 9, p. 2430 - 2433
[3] European Journal of Organic Chemistry, 2015, vol. 2015, # 32, p. 7091 - 7113
[4] Patent: US2004/254231, 2004, A1,
[5] Angewandte Chemie - International Edition, 2011, vol. 50, # 6, p. 1338 - 1341
[6] Arkivoc, 2013, vol. 2013, # 4, p. 334 - 345
[7] Patent: CN104250255, 2016, B, . Location in patent: Paragraph 0055; 0056; 0057; 0058; 0059
[8] Journal of Medicinal Chemistry, 2005, vol. 48, # 1, p. 224 - 239
[9] Patent: WO2005/66162, 2005, A1, . Location in patent: Page/Page column 105
[10] Journal of Organic Chemistry, 2015, vol. 80, # 10, p. 5287 - 5295
[11] Bioorganic and Medicinal Chemistry, 1996, vol. 4, # 5, p. 727 - 737
[12] Journal of Medicinal Chemistry, 2013, vol. 56, # 12, p. 5151 - 5172
[13] Synthesis, 2006, # 18, p. 3080 - 3084
[14] Archives of Pharmacal Research, 2013, vol. 36, # 7, p. 832 - 839
[15] Advanced Synthesis and Catalysis, 2013, vol. 355, # 11-12, p. 2353 - 2360
[16] Organic and Biomolecular Chemistry, 2016, vol. 14, # 24, p. 5606 - 5611
[17] ChemMedChem, 2017, vol. 12, # 24, p. 2044 - 2053
[18] Organic Letters, 2006, vol. 8, # 20, p. 4389 - 4392
[19] Chemical Communications, 2002, # 1, p. 22 - 23
[20] Synlett, 2006, # 7, p. 1110 - 1112
[21] Tetrahedron Letters, 1999, vol. 40, # 19, p. 3811 - 3814
[22] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 19, p. 2713 - 2723
[23] Patent: WO2008/24784, 2008, A1, . Location in patent: Page/Page column 18-19
[24] Patent: WO2012/175962, 2012, A1, . Location in patent: Page/Page column 94
[25] Synthetic Communications, 2014, vol. 44, # 16, p. 2416 - 2425
[26] Patent: US2015/166487, 2015, A1, . Location in patent: Paragraph 0390
[27] Antimicrobial Agents and Chemotherapy, 2016, vol. 60, # 12, p. 7146 - 7152
[28] Patent: WO2008/147764, 2008, A1, . Location in patent: Page/Page column 18-19
[29] Patent: WO2008/147763, 2008, A1, . Location in patent: Page/Page column 19
[30] Advanced Synthesis and Catalysis, 2015, vol. 357, # 18, p. 3943 - 3948
[31] Journal of the American Chemical Society, 1999, vol. 121, # 19, p. 4704 - 4705
[32] Patent: US2014/171447, 2014, A1, . Location in patent: Paragraph 0445; 0446
[33] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1985, p. 2201 - 2208
[34] Tetrahedron, 2009, vol. 65, # 31, p. 6156 - 6168
[35] Synlett, 2003, # 15, p. 2353 - 2353
[36] Synthesis (Germany), 2017, vol. 49, # 17, p. 3945 - 3951
[37] Synlett, 2016, vol. 27, # 18, p. 2575 - 2580
[38] Synlett, 2018, vol. 29, # 6, p. 785 - 792
[39] Advanced Synthesis and Catalysis, 2016, vol. 358, # 18, p. 2912 - 2922
[40] Journal of Organic Chemistry, 2007, vol. 72, # 8, p. 2897 - 2905
[41] Patent: US2005/245530, 2005, A1, . Location in patent: Page/Page column 53-54
[42] Patent: WO2011/103089, 2011, A1, . Location in patent: Page/Page column 42-43
[43] Patent: WO2004/50619, 2004, A1, . Location in patent: Page 74-75
[44] Patent: WO2004/94430, 2004, A1, . Location in patent: Page 23
[45] Patent: US9951069, 2018, B1, . Location in patent: Page/Page column 11-12
[46] Chemistry - A European Journal, 2016, vol. 22, # 29, p. 10150 - 10154
[47] Patent: US2005/26944, 2005, A1,
[48] Patent: JP5846230, 2016, B2, . Location in patent: Paragraph 0170; 0171
[49] Patent: WO2006/104713, 2006, A1, . Location in patent: Page/Page column 98
[50] Journal of Medicinal Chemistry, 2015, vol. 58, # 8, p. 3593 - 3610
[51] Journal of the American Chemical Society, 2013, vol. 135, # 35, p. 13193 - 13203
[52] Patent: WO2006/51290, 2006, A2, . Location in patent: Page/Page column 112
[53] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 7, p. 1241 - 1244
[54] Journal of the American Chemical Society, 2004, vol. 126, # 25, p. 8038 - 8045
[55] Patent: US2003/162788, 2003, A1,
[56] Patent: US2003/73836, 2003, A1,
[57] Patent: US6541505, 2003, B1,
[58] Patent: US5719193, 1998, A,
[59] Patent: US2007/254879, 2007, A1, . Location in patent: Page/Page column 29; 30
[60] Patent: US2009/48277, 2009, A1, . Location in patent: Page/Page column 12
[61] Patent: US2009/36450, 2009, A1, . Location in patent: Page/Page column 34
[62] Patent: WO2005/19174, 2005, A1, . Location in patent: Page/Page column 49
[63] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 15, p. 4635 - 4638
[64] Tetrahedron Letters, 2010, vol. 51, # 45, p. 5915 - 5918
[65] Patent: US2006/223797, 2006, A1, . Location in patent: Page/Page column 90
[66] Patent: WO2007/75896, 2007, A2, . Location in patent: Page/Page column 146
[67] Journal of Fluorine Chemistry, 2011, vol. 132, # 10, p. 850 - 857
[68] Patent: US2011/319418, 2011, A1, . Location in patent: Page/Page column 37
[69] Patent: WO2012/70024, 2012, A1, . Location in patent: Page/Page column 34-65
[70] European Journal of Medicinal Chemistry, 2013, vol. 69, p. 244 - 261
[71] Organic Process Research and Development, 2005, vol. 9, # 4, p. 440 - 450
[72] Patent: US2014/171403, 2014, A1, . Location in patent: Page/Page column
[73] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 2, p. 104 - 112
[74] PLoS ONE, 2017, vol. 12, # 2,
[75] Patent: WO2018/5860, 2018, A1, . Location in patent: Page/Page column 172; 190; 191
  • 4
  • [ 24424-99-5 ]
  • [ 15430-52-1 ]
  • [ 92136-39-5 ]
YieldReaction ConditionsOperation in experiment
96% With triethylamine In dichloromethane for 2 h; Cooling with ice Propargylamine hydrochloride (3.6 g, 39 mmol) and triethylamine (11.5 mL, 83 mmol, 2.13 equiv) were dissolved in CH2Cl2 (100 mL) and this solution was cooled on ice. Then, a solution of Boc2O (8.5 g, 40 mmol), (1.03 equiv) in CH2Cl2 (50 mL) was added dropwise and the obtained reaction mixture was stirred for 2 h. After removing the solvent under reduced pressure, the residue was redissolved in EtOAc (150 mL) and this solution was washed with 1 N KHSO4 (3 x 75 mL) and brine (150 mL). The EtOAc solution was dried (Na2SO4) and concentrated in vacuo to give 8 as pink crystals in 96percent yield (5.8 g). Rf 0.70 (CH2Cl2/MeOH 95:5); 1H NMR (300 MHz, CDCl3, 25 °C): d 4.71 (broad s, 1H; urethane NH), 3.93(m, 2H; CH2), 2.22 (s, 1H; ^CH), 1.46 (s, 9H; C(CH3)3); 13C NMR(75.5 MHz, CDCl3, 25 °C): d 155.3, 80.0, 69.3, 30.4, 28.3, 27.4.
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 88, p. 55 - 65
[2] Organic Letters, 2014, vol. 16, # 12, p. 3196 - 3199
  • 5
  • [ 34619-03-9 ]
  • [ 2450-71-7 ]
  • [ 92136-39-5 ]
YieldReaction ConditionsOperation in experiment
97% for 12 h; Propargyl amine (9.6 g, 174.4 MMOL) was added dropwise to a solution of di-tert-butyl dicarbonate (46.1 g, 211.0 MMOL) in THF (70 mL). After 12 h the reaction was concentrated, the residue was dissolved in diethyl ether and washed with water (1 x) and brine (1 x). The organic layer was dried over NA2SO4 then concentrated to afford the title compound as a yellow oil (26 g, 97percent).
Reference: [1] Patent: WO2004/56830, 2004, A1, . Location in patent: Page 86
  • 6
  • [ 90965-06-3 ]
  • [ 121505-93-9 ]
  • [ 92136-39-5 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 29, p. 5597 - 5599
  • 7
  • [ 4248-19-5 ]
  • [ 106-96-7 ]
  • [ 92136-39-5 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 15, p. 4444 - 4448
  • 8
  • [ 24608-52-4 ]
  • [ 2450-71-7 ]
  • [ 92136-39-5 ]
Reference: [1] Advanced Synthesis and Catalysis, 2009, vol. 351, # 9, p. 1371 - 1377
  • 9
  • [ 4202-14-6 ]
  • [ 89711-08-0 ]
  • [ 92136-39-5 ]
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 3, p. 1254 - 1264
  • 10
  • [ 24424-99-5 ]
  • [ 92136-39-5 ]
Reference: [1] Tetrahedron, 1996, vol. 52, # 20, p. 7037 - 7044
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 92136-39-5 ]

Alkynes

Chemical Structure| 118080-79-8

[ 118080-79-8 ]

(S)-tert-Butyl but-3-yn-2-ylcarbamate

Similarity: 0.92

Chemical Structure| 149990-27-2

[ 149990-27-2 ]

tert-Butyl but-3-yn-1-ylcarbamate

Similarity: 0.88

Chemical Structure| 151978-58-4

[ 151978-58-4 ]

tert-Butyl hex-5-yn-1-ylcarbamate

Similarity: 0.81

Chemical Structure| 287193-01-5

[ 287193-01-5 ]

tert-Butyl 3-ethynylazetidine-1-carboxylate

Similarity: 0.74

Chemical Structure| 255864-58-5

[ 255864-58-5 ]

tert-Butyl 2-ethynylpiperidine-1-carboxylate

Similarity: 0.69

Aliphatic Chain Hydrocarbons

Chemical Structure| 118080-79-8

[ 118080-79-8 ]

(S)-tert-Butyl but-3-yn-2-ylcarbamate

Similarity: 0.92

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.92

Chemical Structure| 149990-27-2

[ 149990-27-2 ]

tert-Butyl but-3-yn-1-ylcarbamate

Similarity: 0.88

Chemical Structure| 122734-32-1

[ 122734-32-1 ]

tert-Butyl (2-(methylamino)ethyl)carbamate

Similarity: 0.87

Chemical Structure| 117499-16-8

[ 117499-16-8 ]

Di-tert-butyl (azanediylbis(ethane-2,1-diyl))dicarbamate

Similarity: 0.85

Amides

Chemical Structure| 118080-79-8

[ 118080-79-8 ]

(S)-tert-Butyl but-3-yn-2-ylcarbamate

Similarity: 0.92

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.92

Chemical Structure| 149990-27-2

[ 149990-27-2 ]

tert-Butyl but-3-yn-1-ylcarbamate

Similarity: 0.88

Chemical Structure| 122734-32-1

[ 122734-32-1 ]

tert-Butyl (2-(methylamino)ethyl)carbamate

Similarity: 0.87

Chemical Structure| 117499-16-8

[ 117499-16-8 ]

Di-tert-butyl (azanediylbis(ethane-2,1-diyl))dicarbamate

Similarity: 0.85

Amines

Chemical Structure| 118080-79-8

[ 118080-79-8 ]

(S)-tert-Butyl but-3-yn-2-ylcarbamate

Similarity: 0.92

Chemical Structure| 38267-76-4

[ 38267-76-4 ]

tert-Butyl ethylcarbamate

Similarity: 0.92

Chemical Structure| 149990-27-2

[ 149990-27-2 ]

tert-Butyl but-3-yn-1-ylcarbamate

Similarity: 0.88

Chemical Structure| 122734-32-1

[ 122734-32-1 ]

tert-Butyl (2-(methylamino)ethyl)carbamate

Similarity: 0.87

Chemical Structure| 117499-16-8

[ 117499-16-8 ]

Di-tert-butyl (azanediylbis(ethane-2,1-diyl))dicarbamate

Similarity: 0.85